Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02003092 |
Title | RX-5902 Treatment of Subjects With Solid Tumors |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Rexahn Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Rexahn site | Tucson | Arizona | 85724 | United States | Details | |
Rexahn Site | Aurora | Colorado | 80045 | United States | Details | |
Rexahn site | Chicago | Illinois | 60637 | United States | Details | |
Rexahn Site | Detroit | Michigan | 48202 | United States | Details | |
Rexahn Site | Hackensack | New Jersey | 07601 | United States | Details | |
Rexahn Site | New York | New York | 10065 | United States | Details | |
Rexahn Site | Greenville | South Carolina | 29605 | United States | Details | |
Rexahn site | Arlington | Virginia | 22031 | United States | Details |